Location: Greenwich, CT
CIK: 0001596452 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 8, 2023
Total Value: $233M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR S&P Biotech ETF | 200,000 | $15.24M | 6.6% | $76.21 | $82.92 | -8.1% | Cash Securities | 78464A870 |
| HUM | Humana Inc | 22,500 | $10.92M | 4.7% | $485.47 * | $422.45 | +11.4% | Cash Securities | 444859102 |
| NVO | Novo Nordisk A/S | 60,000 | $9.548M | 4.1% | $159.13 | $112.99 | +40.8% | Cash Securities | 670100205 |
| THC | Tenet Healthcare Corp | 150,000 | $8.913M | 3.8% | $59.42 | $47.24 | +25.8% | Cash Securities | 88033G407 |
| UNH | UnitedHealth Group Inc | 17,500 | $8.27M | 3.6% | $472.57 * | $409.84 | +9.6% | Cash Securities | 91324P102 |
| MRK | Merck & Co Inc | 75,000 | $7.979M | 3.4% | $106.39 * | $98.68 | -0.9% | Cash Securities | 58933Y105 |
| HCA | HCA Healthcare Inc | 30,000 | $7.91M | 3.4% | $263.67 * | $184.08 | +40.1% | Cash Securities | 40412C101 |
| BSX | Boston Scientific Corp | 155,000 | $7.755M | 3.3% | $50.03 | $39.84 | +25.6% | Cash Securities | 101137107 |
| ZBH | Zimmer Biomet Holdings Inc | 60,000 | $7.752M | 3.3% | $129.20 * | $121.04 | +4.2% | Cash Securities | 98956P102 |
| ISRG | Intuitive Surgical Inc | 30,000 | $7.664M | 3.3% | $255.47 | $282.04 | -9.4% | Cash Securities | 46120E602 |
| SYK | Stryker Corp | 25,000 | $7.137M | 3.1% | $285.48 * | $214.01 | +29.9% | Cash Securities | 863667101 |
| UHS | Universal Health Services Inc | 54,990 | $6.989M | 3.0% | $127.10 | $119.27 | +5.2% | Cash Securities | 913903100 |
| LLY | Eli Lilly & Co | 20,000 | $6.868M | 3.0% | $343.40 * | $255.49 | +31.7% | Cash Securities | 532457108 |
| COR | AmerisourceBergen Corp | 40,000 | $6.404M | 2.8% | $160.10 * | $113.77 | +37.3% | Cash Securities | 03073E105 |
| ABBV | AbbVie Inc | 40,000 | $6.375M | 2.7% | $159.38 * | $138.12 | +4.4% | Cash Securities | 00287Y109 |
| TMO | Thermo Fisher Scientific Inc | 11,000 | $6.34M | 2.7% | $576.36 | $544.32 | +5.0% | Cash Securities | 883556102 |
| BAX | Baxter International Inc | 150,000 | $6.084M | 2.6% | $40.56 * | $61.88 | -38.8% | Cash Securities | 071813109 |
| CAH | Cardinal Health Inc | 80,000 | $6.04M | 2.6% | $75.50 * | $54.38 | +32.4% | Cash Securities | 14149Y108 |
| SGRY | Surgery Partners Inc | 175,000 | $6.032M | 2.6% | $34.47 | $38.07 | -9.4% | Cash Securities | 86881A100 |
| A | Agilent Technologies Inc | 40,000 | $5.534M | 2.4% | $138.35 * | $122.09 | +11.0% | Cash Securities | 00846U101 |
| MDT | Medtronic PLC | 67,500 | $5.442M | 2.3% | $80.62 * | $74.52 | -0.3% | Cash Securities | G5960L103 |
| MCK | McKesson Corp | 15,000 | $5.341M | 2.3% | $356.07 | $159.43 | +120.4% | Cash Securities | 58155Q103 |
| ACHC | Acadia Healthcare Co Inc | 70,000 | $5.058M | 2.2% | $72.26 | $61.43 | +17.6% | Cash Securities | 00404A109 |
| DHR | Danaher Corp | 20,000 | $5.041M | 2.2% | $252.05 * | $126.96 | +73.5% | Cash Securities | 235851102 |
| BMRN | BioMarin Pharmaceutical Inc | 50,000 | $4.862M | 2.1% | $97.24 | $84.12 | +15.6% | Cash Securities | 09061G101 |
| ELV | Elevance Health Inc | 10,543 | $4.848M | 2.1% | $459.83 * | $411.15 | +7.2% | Cash Securities | 036752103 |
| VRTX | Vertex Pharmaceuticals Inc | 15,000 | $4.726M | 2.0% | $315.07 | $304.77 | +3.4% | Cash Securities | 92532F100 |
| WAT | Waters Corp | 15,000 | $4.644M | 2.0% | $309.60 | $319.20 | -3.0% | Cash Securities | 941848103 |
| ABT | Abbott Laboratories | 45,000 | $4.557M | 2.0% | $101.27 * | $92.07 | +4.2% | Cash Securities | 002824100 |
| IQV | IQVIA Holdings Inc | 20,000 | $3.978M | 1.7% | $198.90 | $193.98 | +2.5% | Cash Securities | 46266C105 |
| CI | Cigna Group/The | 15,000 | $3.833M | 1.6% | $255.53 * | $222.95 | +9.0% | Cash Securities | 125523100 |
| BDX | Becton Dickinson & Co | 15,000 | $3.713M | 1.6% | $247.53 * | $232.23 | +1.5% | Cash Securities | 075887109 |
| — | Seagen Inc | 16,000 | $3.24M | 1.4% | $202.50 | $152.11 | — | Cash Securities | 81181C104 |
| ICLR | ICON PLC | 15,000 | $3.204M | 1.4% | $213.60 | $198.26 | +7.7% | Cash Securities | G4705A100 |
| EHC | Encompass Health Corp | 55,000 | $2.976M | 1.3% | $54.11 * | $51.60 | +2.7% | Cash Securities | 29261A100 |
| SEM | Select Medical Holdings Corp | 107,838 | $2.788M | 1.2% | $25.85 * | $15.52 | -14.4% | Cash Securities | 81619Q105 |
| BIIB | Biogen Inc | 10,000 | $2.78M | 1.2% | $278.00 | $212.38 | +30.9% | Cash Securities | 09062X103 |
| OPCH | Option Care Health Inc | 80,000 | $2.542M | 1.1% | $31.77 | $25.08 | +26.7% | Cash Securities | 68404L201 |
| SRPT | Sarepta Therapeutics Inc | 13,000 | $1.792M | 0.8% | $137.85 | $129.72 | +6.3% | Cash Securities | 803607100 |
| ALNY | Alnylam Pharmaceuticals Inc | 7,500 | $1.502M | 0.6% | $200.27 | $210.20 | -4.7% | Cash Securities | 02043Q107 |